Author(s):
Smail Kharoubi
Epistaxis is a common clinical condition in the general population. While it is often benign and resolves spontaneously, it can sometimes be severe due to its frequency, recurrence, etiology, or the patient's underlying comorbidities.
Management must be cautious, tailored to each individual case, and gradual following the principle of therapeutic escalation,and may sometimes require a multidisciplinary approach.
General practitioners are often on the front lines, playing a crucial role in diagnosis, assessing severity, and identifying cases that require specialist referral. Recent data on epistaxis have revealed the emergence of new etiologies (such as toxic and inflammatory diseases) and, most importantly, a shift in management strategies toward atraumatic treatments using modern hemostasis techniques, including bioresorbable agents and procoagulant balloons. Surgical ligation of the sphenopalatine artery and embolization remain valuable, complementary treatments for severe, refractory, or patient-specific epistaxis.